rituximab
Showing 2301 - 2325 of 2,665
END STAGE RENAL DISEASE Trial in Guadalajara (ESW group)
Completed
- END STAGE RENAL DISEASE
- ESW group
-
Guadalajara, Jalisco, MexicoUmae Hospital de Especialidades
Dec 26, 2014
Lymphoma Trial (biological, drug, genetic, other)
Unknown status
- Lymphoma
- rituximab
- +10 more
- (no location specified)
Aug 1, 2013
Lymphoma Trial in New York (aldesleukin, rituximab)
Completed
- Lymphoma
- aldesleukin
- rituximab
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jul 17, 2013
DLBCL Trial in Austria (Rituximab, Cyclophosphamide, Doxorubicin)
Completed
- Diffuse Large B-Cell Lymphoma
- Rituximab
- +5 more
-
Feldkirch, Austria
- +9 more
Aug 29, 2013
GVHD Trial in Tampa (Visilizumab, Tacrolimus, Methotrexate)
Terminated
- Graft Versus Host Disease
- Visilizumab
- +3 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center & Research Institute
Jul 10, 2014
Lymphoma Trial in Houston (Rituximab, Adriamycin, Bleomycin)
Completed
- Lymphoma
- Rituximab
- +4 more
-
Houston, TexasUT MD . Anderson Cancer Center
May 20, 2013
Leukemia Trial in United States (alemtuzumab, rituximab, fludarabine phosphate)
Completed
- Leukemia
- alemtuzumab
- +2 more
-
Boston, Massachusetts
- +4 more
Aug 1, 2013
Leukemia, Lymphoma Trial in Philadelphia (rituximab, epirubicin HCl)
Completed
- Leukemia
- Lymphoma
- rituximab
- epirubicin hydrochloride
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Jul 10, 2013
Diffuse Large B-cell Lymphoma Trial in Italy (Bendamustine+Rituximab)
Unknown status
- Diffuse Large B-cell Lymphoma
-
Acquaviva Delle Fonti, Bari, Italy
- +51 more
Nov 15, 2013
Multiple Myeloma and Plasma Cell Tumor Trial in Cleveland (rituximab, melphalan, prednisone)
Completed
- Multiple Myeloma and Plasma Cell Neoplasm
- rituximab
- +2 more
-
Cleveland, OhioCleveland Clinic Taussig Cancer Center
Jul 17, 2013
Lymphoma Trial in Worldwide (biological, drug, radiation)
Completed
- Lymphoma
- rituximab
- +5 more
-
Birmingham, Alabama
- +86 more
Jan 27, 2014
Follicular Non-Hodgking´s Lymphoma Refractory or Relapsed After Treatment With R-chemotherapy in First Line. Trial in Spain
Unknown status
- Follicular Non-Hodgking´s Lymphoma Refractory or Relapsed After Treatment With R-chemotherapy in First Line.
- Rituximab and Bendamustine
-
Elche, Alicante, Spain
- +17 more
Aug 22, 2013
End Stage Renal Disease Trial in Seoul (Transplantation Conditioning for BMT)
Unknown status
- End Stage Renal Disease
- Transplantation Conditioning for BMT
-
Seoul, Korea, Republic ofSamsung Medical Center, Organ Transplant Center
Jul 22, 2014
Lymphoma, Large-Cell, Diffuse Trial in Nantes (CHOP+RITUXIMAB, CEEP-RITUXIMAB)
Completed
- Lymphoma, Large-Cell, Diffuse
-
Nantes, FranceNantes University Hospital
Jun 12, 2013
Lymphoma Trial in United Kingdom (biological, dietary supplement, drug, other)
Withdrawn
- Lymphoma
- filgrastim
- +7 more
-
London, England, United Kingdom
- +4 more
Aug 23, 2013
MALT, Hematopoietic/Lymphoid Cancer, Nodal Marginal Zone B-cell Lymphoma Trial in United States (bortezomib, fludarabine
Completed
- Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
- +11 more
- bortezomib
- +2 more
-
Canton, Ohio
- +6 more
Sep 27, 2013
DLBCL Trial in Paris (rituximab, vinorelbine, ifosfamide)
Completed
- Diffuse Large B-Cell Lymphoma
- rituximab
- +4 more
-
Paris, FranceHôpital COCHIN
Jul 23, 2013
Lymphoma Trial in New York (filgrastim, rituximab, carboplatin)
Completed
- Lymphoma
- filgrastim
- +4 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jun 18, 2013
Blood And Marrow Transplantation, Leukemia, Lymphoma Trial in United States (Fludarabine, Clofarabine, Busulfan, ATG, TBI
Unknown status
- Blood And Marrow Transplantation
- +6 more
- Fludarabine, Clofarabine, Busulfan, ATG, TBI (Myeloablative)
- Fludarabine, Melphalan, ATG (Reduced Intensity)
-
La Jolla, California
- +3 more
Nov 14, 2013
GVHD Trial in Boston (Rituximab)
Completed
- Graft vs Host Disease
- Rituximab
-
Boston, Massachusetts
- +1 more
Jun 10, 2013
Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Shanghai (Rabbit Anti-human Thymocyte Globulin (ATG))
Unknown status
- Acute Lymphoblastic Leukemia
- Lymphoblastic Lymphoma
- Rabbit Anti-human Thymocyte Globulin (ATG)
-
Shanghai, Shanghai, ChinaShanghai First People's HOSPITAL
Nov 8, 2014
Leukemia Trial in United Kingdom (rituximab, cyclophosphamide, fludarabine phosphate)
Completed
- Leukemia
- rituximab
- +3 more
-
Birmingham, England, United Kingdom
- +15 more
Aug 1, 2013
Mantle Cell Lymphoma Trial (Intensive Induction-BMT)
Completed
- Mantle Cell Lymphoma
- Intensive Induction-BMT
- (no location specified)
Jul 16, 2014